Studies that are eligible for Clinical Research Network (CRN) support are added to the NIHR Clinical Research Network Portfolio.
The eligibility assessment for access to CRN support on behalf of the Department of Health and Social Care (in England) is performed by:
Studies are identified as being either one of the following types:
All studies, regardless of type, must:
Research can be defined as the attempt to derive generalisable or transferable new knowledge to answer or refine relevant questions with scientifically sound methods. This excludes: audit; needs assessments; quality improvement and other local service evaluations. It also excludes routine banking of biological samples or data except where this activity is integral to a self-contained research project designed to test a clear hypothesis.
From 1 January 2018, the NIHR Clinical Research Network (CRN) extended support into health and social care research taking place in non-NHS settings. The Department of Health and Social Care has agreed an important change to the criteria that describes which clinical research studies can benefit from CRN support. The change to the policy means the CRN can support research conducted outside of NHS settings, such as studies running in care homes or in hospices. Read the full announcement and view the new policy which became effective on 1 January 2018.
NIHR non-commercial Partners are organisations that:
Industry sponsored studies that have been submitted for Network feasibility services and confirmed as both eligible and feasible for inclusion into the NIHR CRN Portfolio as part of this process will be classed as high priority.